STLN
Starling Oncology, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$6.46
+0.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 72.39x
- P/S forward
- 0.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -26.43x
- Price / sales
- 1.12x
- Price / cash flow
- 2007.25x
Enterprise value
- Enterprise value
- $721.8M
- EV / sales
- 1.23x
- EV / EBITDA
- -33.02x
- EV / EBIT
- -27.66x
- Market cap
- $658.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026